COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 637: Articles 6361-6370  | Next

Use of a Self-Care and Educational Mobile App to Improve Outcomes of Patients with Acute Decompensated Heart Failure during the COVID-19 Pandemic
essa, h. a., Jackson, C., Nyjo, S., Kelly, A., Murphy, N., Hartshorne-Evans, N., Walker, L., Oguguo, E., Douglas, H., Sankaranarayanan, R.
10.1101/2022.07.28.22270513 — Posted: 2022-08-01
InterClone: Store, Search and Cluster Adaptive Immune Receptor Repertoires
Wilamowski, J., Xu, Z., Ismanto, H. S., Li, S., Teraguchi, S., Covarrubias, M. A. L., Lu, X., Yamasaki, S., Standley, D. M.
10.1101/2022.07.31.501809 — Posted: 2022-08-01
Recombinant Human ACE2-Fc : A promising therapy for SARS-CoV2 infection
P.K, S., Shandil, R. K., Suresh, P., Biswas, K., Rudramurthy, G. R., Nanjegowda, N. C., Kumaraswamy, B., Battula, N. P., Chowdhury, S. D., Sinha, S., Dutta, S., Dhar, S. K., Narayanan, S., Das, M.
10.1101/2022.07.30.501940 — Posted: 2022-08-01
Epitranscriptomic N6-methyladenosine profile of SARS-CoV-2-infected human lung epithelial cells
Phillips, S., Khadka, S., Bohan, D., Espada, C. E., Maury, W., Wu, L.
10.1101/2022.08.01.502311 — Posted: 2022-08-01
SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses
Kohyama, M., Suzuki, T., Nakai, W., Ono, C., Matsuoka, S., Iwatani, K., Liu, Y., Sakai, Y., Nakagawa, A., Tomii, K., Ohmura, K., Okada, M., Matsuura, Y., Oshima, S., Maeda, Y., Okamoto, T., Arase, H.
10.1101/2022.08.01.502275 — Posted: 2022-08-01
Coronaviruses using different strategies to antagonize antiviral responses and pyroptosis
Fu, X., Yang, Y., Xu, W., Li, D., Li, X., Chen, N., Lv, Q., Shi, Y., Li, X., Shi, F.
10.1101/2022.07.29.502014 — Posted: 2022-08-01
Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant.
Mise-Omata, S., Ikeda, M., Takeshita, M., Uwamino, Y., Wakui, M., Arai, T., Yoshifuji, A., Murano, K., Siomi, H., Nakagawara, K., Ohyagi, M., Ando, M., Hasegawa, N., Saya, H., Murata, M., Fukunaga, K., Namkoong, H., Lu, X., Yamasaki, S., Yoshimura, A.
10.1101/2022.07.31.500554 — Posted: 2022-08-01
Evolution to increased positive charge on the viral spike protein may be part of the adaptation of SARS-CoV-2 to human transmission
Cotten, M., Phan, M. V. T.
10.1101/2022.07.30.502143 — Posted: 2022-08-01
Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
Wang, Q., Iketani, S., Li, Z., Guo, Y., Yeh, A. Y., Liu, M., Yu, J., Sheng, Z., Huang, Y., Liu, L., Ho, D. D.
10.1101/2022.07.31.502235 — Posted: 2022-08-01
Risk of Myocarditis after Covid-19 mRNA Vaccination: Impact of Booster Dose and Dosing Interval
Le Vu, S., Bertrand, M., Jabagi, M.-J., Botton, J., Weill, A., Dray-Spira, R., Zureik, M.
10.1101/2022.07.31.22278064 — Posted: 2022-08-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).